| NCT03369730 |
Reducing the Duration of Untreated Psychosis in the United States |
https://ClinicalTrials.gov/show/NCT03369730 |
Recruiting |
Icahn School of Medicine at Mount Sinai |
2020-09-15 |
| NCT03820362 |
The Role of Personal Identity in Psychotic Symptoms: a Study With the Repertory Grid Technique |
https://ClinicalTrials.gov/show/NCT03820362 |
Completed |
University of Barcelona |
2018-11-30 |
| NCT00001486 |
Genetic Study of Schizophrenia |
https://ClinicalTrials.gov/show/NCT00001486 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03271242 |
Implementation of National Guidelines for Treatment of Psychoses |
https://ClinicalTrials.gov/show/NCT03271242 |
Completed |
University Hospital, Akershus |
2018-12-31 |
| NCT03253367 |
Phenomics and Genomics of Clozapine Pharmacotherapy |
https://ClinicalTrials.gov/show/NCT03253367 |
Recruiting |
UMC Utrecht |
2021-12-31 |
| NCT03248180 |
Guided Dose Reduction of Antipsychotic in Patients With Psychosis in Remitted States |
https://ClinicalTrials.gov/show/NCT03248180 |
Recruiting |
National Taiwan University Hospital |
2020-12-31 |
| NCT03235908 |
Copeptin in Outcome Prediction of an Acute Psychotic Episode |
https://ClinicalTrials.gov/show/NCT03235908 |
Active, not recruiting |
University Hospital, Basel, Switzerland |
2020-07-31 |
| NCT03166098 |
The Role of Dysmyelination in Cognitive Impairment of Psychotic Spectrum Disorders |
https://ClinicalTrials.gov/show/NCT03166098 |
Active, not recruiting |
NYU Langone Health |
2020-11-30 |
| NCT03152292 |
The INSYTE (Management of Parkinson’s Disease Psychosis in Actual Practice) Study |
https://ClinicalTrials.gov/show/NCT03152292 |
Recruiting |
ACADIA Pharmaceuticals Inc. |
2021-09-30 |
| NCT03102151 |
Reducing the Duration of Untreated Psychosis |
https://ClinicalTrials.gov/show/NCT03102151 |
Active, not recruiting |
University of Southern California |
2019-08-30 |
| NCT03076346 |
Neural Biomarkers of Clozapine Response |
https://ClinicalTrials.gov/show/NCT03076346 |
Recruiting |
University of Pittsburgh |
2020-06-30 |
| NCT03049800 |
Is Cognitive Training Neuroprotective in Early Psychosis? |
https://ClinicalTrials.gov/show/NCT03049800 |
Recruiting |
University of Minnesota |
2020-06-12 |
| NCT02921243 |
Schizophrenia and the Gut Microbiome |
https://ClinicalTrials.gov/show/NCT02921243 |
Completed |
University of Maryland, Baltimore |
2019-06-18 |
| NCT02916303 |
Cost-effectiveness of Interventions in First-episode Psychosis |
https://ClinicalTrials.gov/show/NCT02916303 |
Enrolling by invitation |
Fundación Marques de Valdecilla |
2017-07-31 |
| NCT02897167 |
Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia Patients |
https://ClinicalTrials.gov/show/NCT02897167 |
Completed |
Fundación Marques de Valdecilla |
2018-12-31 |
| NCT02822092 |
Striatal Connectivity and Clinical Outcome in Psychosis |
https://ClinicalTrials.gov/show/NCT02822092 |
Recruiting |
Northwell Health |
2021-10-31 |
| NCT02782507 |
Cognitive Therapy for Distressing Visual Hallucinations: A Pilot Study |
https://ClinicalTrials.gov/show/NCT02782507 |
Completed |
Newcastle University |
2013-12-31 |
| NCT02775864 |
Comparative Effectiveness of Adaptive Treatment Strategies for Schizophrenia |
https://ClinicalTrials.gov/show/NCT02775864 |
Completed |
New York State Psychiatric Institute |
2018-04-30 |
| NCT02739932 |
Adolescent Mental Health: Canadian Psychiatric Risk and Outcome Study |
https://ClinicalTrials.gov/show/NCT02739932 |
Active, not recruiting |
University of Calgary |
2021-08-31 |
| NCT02693327 |
Microbiome and the Gut-Brain Axis |
https://ClinicalTrials.gov/show/NCT02693327 |
Completed |
University of Florida |
2017-09-30 |
| NCT02582736 |
Antipsychotics and Risk of Hyperglycemic Emergencies |
https://ClinicalTrials.gov/show/NCT02582736 |
Completed |
Canadian Network for Observational Drug Effect Studies, CNODES |
2012-12-31 |
| NCT00942981 |
Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography |
https://ClinicalTrials.gov/show/NCT00942981 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02034253 |
Glutamate, Brain Connectivity and Duration of Untreated Psychosis |
https://ClinicalTrials.gov/show/NCT02034253 |
Completed |
University of Alabama at Birmingham |
2018-11-30 |
| NCT02505022 |
Role Functioning Changes NOS |
https://ClinicalTrials.gov/show/NCT02505022 |
Recruiting |
Northwestern University |
2021-01-31 |
| NCT02483130 |
Effect of N-acetylcysteine on Brain Glutamate |
https://ClinicalTrials.gov/show/NCT02483130 |
Completed |
King’s College London |
2017-02-28 |
| NCT02401984 |
Zurcher Adolescent Screening for Mental Disorder |
https://ClinicalTrials.gov/show/NCT02401984 |
Completed |
Zurich University of Applied Sciences |
2015-07-31 |
| NCT02321943 |
Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study |
https://ClinicalTrials.gov/show/NCT02321943 |
Completed |
Sykehuset Innlandet HF |
2016-12-31 |
| NCT02218853 |
Psychosis and Affective Research Domains and Intermediate Phenotypes |
https://ClinicalTrials.gov/show/NCT02218853 |
Completed |
University of Texas Southwestern Medical Center |
2017-06-30 |
| NCT01309373 |
An Epidemiological Study to Assess the Psychosocial and Symptomatic Remission and Community Integration Status in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01309373 |
Completed |
Janssen-Cilag, S.A. |
NA |
| NCT01269710 |
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study |
https://ClinicalTrials.gov/show/NCT01269710 |
Completed |
University of North Carolina, Chapel Hill |
2011-03-31 |
| NCT02009826 |
Psychosis-Associated Neuroinflammation in Schizophrenia |
https://ClinicalTrials.gov/show/NCT02009826 |
Completed |
Universiteit Antwerpen |
2017-02-28 |
| NCT01924715 |
Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study |
https://ClinicalTrials.gov/show/NCT01924715 |
Completed |
Nova Scotia Health Authority |
2009-03-31 |
| NCT01786369 |
Adherence in Patients Admitted to a Psychiatric Unit for Acute Psychosis: an Analysis of Serum Levels of Antipsychotics. |
https://ClinicalTrials.gov/show/NCT01786369 |
Completed |
Northwell Health |
2015-04-30 |
| NCT01754532 |
Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels |
https://ClinicalTrials.gov/show/NCT01754532 |
Completed |
Shalvata Mental Health Center |
2015-06-30 |
| NCT01753284 |
First Episode Psychosis and Pathway to Care in Nordland |
https://ClinicalTrials.gov/show/NCT01753284 |
Completed |
Nordlandssykehuset HF |
2018-10-31 |
| NCT01739127 |
Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI |
https://ClinicalTrials.gov/show/NCT01739127 |
Completed |
University of British Columbia |
2016-02-29 |
| NCT01701765 |
Outcomes and Discharge of Long-stay Psychiatric Patients |
https://ClinicalTrials.gov/show/NCT01701765 |
Completed |
IRCCS Centro San Giovanni di Dio Fatebenefratelli |
2011-01-31 |
| NCT01695395 |
Mental Health Care Provision for Adults With Intellectual Disability and a Mental Disorder |
https://ClinicalTrials.gov/show/NCT01695395 |
Completed |
Technische Universität Dresden |
2014-04-30 |
| NCT01569347 |
Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers |
https://ClinicalTrials.gov/show/NCT01569347 |
Completed |
Assistance Publique - Hôpitaux de Paris |
2016-11-30 |
| NCT01518049 |
Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD) |
https://ClinicalTrials.gov/show/NCT01518049 |
Completed |
Aarhus University Hospital |
2013-09-30 |
| NCT01480037 |
Genetic and Physiological Aspects of Oxidative Profile in Sleep and Well-succeed Aging |
https://ClinicalTrials.gov/show/NCT01480037 |
Completed |
Associação Fundo de Incentivo à Pesquisa |
2011-06-30 |
| NCT01425684 |
Brain Circuits in Schizophrenia and Smoking |
https://ClinicalTrials.gov/show/NCT01425684 |
Recruiting |
University of Maryland, Baltimore |
2020-01-31 |
| NCT01425671 |
Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States |
https://ClinicalTrials.gov/show/NCT01425671 |
Active, not recruiting |
University of Maryland, Baltimore |
2020-01-31 |
| NCT01409109 |
Database Registry for Neural Network Biomarkers in Psychosis |
https://ClinicalTrials.gov/show/NCT01409109 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2023-05-31 |
| NCT01392885 |
Brain Health and Exercise in Schizophrenia |
https://ClinicalTrials.gov/show/NCT01392885 |
Enrolling by invitation |
BC Mental Health and Addictions Research Institute |
2016-06-30 |
| NCT01385709 |
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels |
https://ClinicalTrials.gov/show/NCT01385709 |
Completed |
Weill Medical College of Cornell University |
2012-08-31 |
| NCT01384604 |
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders |
https://ClinicalTrials.gov/show/NCT01384604 |
Completed |
University of Texas Southwestern Medical Center |
2013-05-31 |
| NCT04369677 |
Thermoregulation Among Individuals With First-episode Psychosis |
https://ClinicalTrials.gov/show/NCT04369677 |
Recruiting |
Ohio State University |
2021-04-03 |
| NCT04335916 |
Survey on Pre-ECT Evaluation and ECT Application |
https://ClinicalTrials.gov/show/NCT04335916 |
Recruiting |
KliniÄki BolniÄki Centar Zagreb |
2020-09-01 |
| NCT04304417 |
The Role of Group Identity on the Community Integration of People With Severe Mental Disorder |
https://ClinicalTrials.gov/show/NCT04304417 |
Recruiting |
Universidad Complutense de Madrid |
2020-03-31 |
| NCT04280367 |
Learning and Executive Function Disorders in Children and Psychosis Risk at Adult-age |
https://ClinicalTrials.gov/show/NCT04280367 |
Recruiting |
Assistance Publique - Hôpitaux de Paris |
2021-02-28 |
| NCT04200300 |
Professional Quality of Life in German Mental Health Nursing |
https://ClinicalTrials.gov/show/NCT04200300 |
Recruiting |
Charite University, Berlin, Germany |
2020-12-31 |
| NCT04200274 |
Physical Activity Recommendation Behaviour in German Mental Health Nurses |
https://ClinicalTrials.gov/show/NCT04200274 |
Recruiting |
Charite University, Berlin, Germany |
2020-12-31 |
| NCT04165733 |
Professional Quality of Life in German Psychiatrists |
https://ClinicalTrials.gov/show/NCT04165733 |
Recruiting |
Charite University, Berlin, Germany |
2020-12-31 |
| NCT04165720 |
Physical Activity Recommendation Behaviour in German Psychiatrists |
https://ClinicalTrials.gov/show/NCT04165720 |
Recruiting |
Charite University, Berlin, Germany |
2020-12-31 |
| NCT04149912 |
Professional Quality of Life in German Psychologists |
https://ClinicalTrials.gov/show/NCT04149912 |
Recruiting |
Charite University, Berlin, Germany |
2020-12-31 |
| NCT04149795 |
Physical Activity Recommendation Behaviour in German Psychologists |
https://ClinicalTrials.gov/show/NCT04149795 |
Recruiting |
Charite University, Berlin, Germany |
2020-12-31 |
| NCT04051775 |
Non-Pharmacological Treatment of Psychosis |
https://ClinicalTrials.gov/show/NCT04051775 |
Recruiting |
Haukeland University Hospital |
2022-06-30 |
| NCT04024371 |
Validating Reward-related Biomarkers (RTOC) |
https://ClinicalTrials.gov/show/NCT04024371 |
Recruiting |
Maastricht University |
2020-08-01 |
| NCT04021719 |
OnTrackNY’s Learning Healthcare System |
https://ClinicalTrials.gov/show/NCT04021719 |
Recruiting |
New York State Psychiatric Institute |
2024-07-30 |
| NCT03999931 |
Study on the Difference of Plasma microRNA Expression in Patients With Genetic Susceptibility to Mental Disorders |
https://ClinicalTrials.gov/show/NCT03999931 |
Completed |
Second Affiliated Hospital, School of Medicine, Zhejiang University |
2015-01-01 |
| NCT03995121 |
SV2 PET Imaging With [11C]APP311 |
https://ClinicalTrials.gov/show/NCT03995121 |
Active, not recruiting |
Yale University |
2023-12-31 |
| NCT03984084 |
Biological Classification of Mental Disorders |
https://ClinicalTrials.gov/show/NCT03984084 |
Recruiting |
Max-Planck-Institute of Psychiatry |
2025-12-31 |
| NCT03965598 |
Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group |
https://ClinicalTrials.gov/show/NCT03965598 |
Recruiting |
Second Xiangya Hospital of Central South University |
2021-12-31 |
| NCT03932188 |
Brain Imaging in Early Psychosis |
https://ClinicalTrials.gov/show/NCT03932188 |
Recruiting |
Washington University School of Medicine |
2021-04-30 |
| NCT03919760 |
Early Psychosis Intervention - Spreading Evidence-based Treatment |
https://ClinicalTrials.gov/show/NCT03919760 |
Recruiting |
Centre for Addiction and Mental Health |
2023-05-31 |
| NCT03774641 |
A Pilot Study of Prophylactic Management of Lamotrigine in Pregnant Women |
https://ClinicalTrials.gov/show/NCT03774641 |
Recruiting |
Johns Hopkins University |
2020-12-31 |
| NCT03689296 |
Patient-caregiver Collaboration for Better Cardiovascular Care for Patients With Long-term Mental Disorders: Multicentre Qualitative and Feasibility Studies |
https://ClinicalTrials.gov/show/NCT03689296 |
Recruiting |
Centre Hospitalier Universitaire Dijon |
2021-12-31 |
| NCT00836251 |
Effects of Antipsychotic Medications on Energy Intake and Expenditure |
https://ClinicalTrials.gov/show/NCT00836251 |
Completed |
Washington University School of Medicine |
2008-06-30 |
| NCT03558529 |
Feasibility and Acceptability of a Smartphone App to Assess Early Warning Signs of Psychosis Relapse |
https://ClinicalTrials.gov/show/NCT03558529 |
Completed |
Manchester Academic Health Science Centre |
2018-04-01 |
| NCT03525054 |
Semantic and Syntactic Computerized Analysis of Free Speech |
https://ClinicalTrials.gov/show/NCT03525054 |
Recruiting |
University Hospital, Brest |
2022-05-18 |
| NCT03501160 |
Socially Inappropriate Behaviour in People With First Episode Psychosis: A Caregivers’ Perspective |
https://ClinicalTrials.gov/show/NCT03501160 |
Active, not recruiting |
Chinese University of Hong Kong |
2020-04-30 |
| NCT03485339 |
Substance Misuse To Psychosis for Ketamine (SToP-K) |
https://ClinicalTrials.gov/show/NCT03485339 |
Active, not recruiting |
The University of Hong Kong |
2020-06-05 |
| NCT03481465 |
Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis |
https://ClinicalTrials.gov/show/NCT03481465 |
Enrolling by invitation |
Fundación Marques de Valdecilla |
2019-12-31 |
| NCT03476473 |
Early Detection of Respiratory Disorders in Psychosis |
https://ClinicalTrials.gov/show/NCT03476473 |
Enrolling by invitation |
Fundación Marques de Valdecilla |
2018-03-26 |
| NCT03449407 |
Multi-dimensional Investigations of Negative Emotions and Drug-resistant Auditory Verbal Hallucinations in Psychosis |
https://ClinicalTrials.gov/show/NCT03449407 |
Completed |
Chinese University of Hong Kong |
2019-06-30 |
| NCT03414151 |
Gut Microbiome in AP Naive |
https://ClinicalTrials.gov/show/NCT03414151 |
Recruiting |
Centre for Addiction and Mental Health |
2022-03-31 |
| NCT01196858 |
Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland |
https://ClinicalTrials.gov/show/NCT01196858 |
Completed |
University Hospital of North Norway |
2013-09-30 |
| NCT01092598 |
Factors Association With Poor Physical Function in Older Adults With Schizophrenia |
https://ClinicalTrials.gov/show/NCT01092598 |
Completed |
University of California, San Francisco |
2012-06-30 |
| NCT01043250 |
Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients |
https://ClinicalTrials.gov/show/NCT01043250 |
Completed |
Samsung Medical Center |
2010-04-30 |
| NCT01036568 |
Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia |
https://ClinicalTrials.gov/show/NCT01036568 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01028196 |
Observational Study to Evaluate Bipolar Disorder Symptoms in Patients Presented With Schizophrenia or Depression |
https://ClinicalTrials.gov/show/NCT01028196 |
Completed |
AstraZeneca |
2010-11-30 |
| NCT01011088 |
Paternal Psychosis After Baby Born |
https://ClinicalTrials.gov/show/NCT01011088 |
Completed |
Nanjing Medical University |
2010-05-31 |
| NCT01001481 |
Schizophrenia Treatment Adherence Investigation (STAI) |
https://ClinicalTrials.gov/show/NCT01001481 |
Completed |
Janssen-Cilag Pty Ltd |
2009-09-30 |
| NCT00913731 |
Quality Project to Evaluate and Validate the FAST-O Rating Scale |
https://ClinicalTrials.gov/show/NCT00913731 |
Completed |
AstraZeneca |
NA |
| NCT00903916 |
Effect of Antipsychotics on Appetite Regulation |
https://ClinicalTrials.gov/show/NCT00903916 |
Completed |
University of North Carolina, Chapel Hill |
2012-03-31 |
| NCT00894738 |
Biomarkers of Cardiometabolic Risk in Children Treated With Antipsychotics: A Preliminary Study of Direct Measures |
https://ClinicalTrials.gov/show/NCT00894738 |
Completed |
Washington University School of Medicine |
2016-03-31 |
| NCT00872313 |
Risk Factors for Postpartum Psychosis |
https://ClinicalTrials.gov/show/NCT00872313 |
Completed |
Nanjing Medical University |
2012-08-31 |
| NCT00780585 |
A Follow up Safety Study of Patients Who Participated in Previous Studies of the Drug Org 24448 (Study P05719)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00780585 |
Completed |
Merck Sharp & Dohme Corp. |
2009-01-31 |
| NCT00749970 |
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00749970 |
Completed |
AstraZeneca |
2009-01-31 |
| NCT00691535 |
Genetics of Symptomatology and Treatment Response in Psychotic Major Depression |
https://ClinicalTrials.gov/show/NCT00691535 |
Completed |
Stanford University |
2012-06-30 |
| NCT00683709 |
Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder |
https://ClinicalTrials.gov/show/NCT00683709 |
Completed |
St. Joseph’s Healthcare Hamilton |
2011-07-31 |
| NCT00680888 |
Adherence in Adolescents and Children Treated on Quetiapine |
https://ClinicalTrials.gov/show/NCT00680888 |
Completed |
AstraZeneca |
2008-08-31 |
| NCT00670371 |
Factors of Importance for the Subjective and Objective Burden of Informal Caregivers to Patients With Functional Psychoses - a Descriptive and Comparative Study |
https://ClinicalTrials.gov/show/NCT00670371 |
Completed |
AstraZeneca |
NA |
| NCT00644852 |
Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone |
https://ClinicalTrials.gov/show/NCT00644852 |
Completed |
Johnson & Johnson Taiwan Ltd |
2007-09-30 |
| NCT00627510 |
Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission |
https://ClinicalTrials.gov/show/NCT00627510 |
Completed |
Medical University Innsbruck |
2005-07-31 |
| NCT00579267 |
Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID) |
https://ClinicalTrials.gov/show/NCT00579267 |
Completed |
University of South Florida |
2008-01-31 |
| NCT00576095 |
Clinical and Biological Characteristics of Psychotic Depression |
https://ClinicalTrials.gov/show/NCT00576095 |
Completed |
Stanford University |
2012-06-30 |
| NCT00538122 |
Changes in Heart Rhythms Associated With Antipsychotic Drug Treatment |
https://ClinicalTrials.gov/show/NCT00538122 |
Completed |
Vanderbilt University |
2008-07-31 |
| NCT00523783 |
Seroquel Long-Term NIS for Schizophrenia Patients |
https://ClinicalTrials.gov/show/NCT00523783 |
Completed |
AstraZeneca |
2007-11-30 |
| NCT00458367 |
RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice |
https://ClinicalTrials.gov/show/NCT00458367 |
Completed |
Janssen Pharmaceutica N.V., Belgium |
NA |
| NCT00454883 |
Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders. |
https://ClinicalTrials.gov/show/NCT00454883 |
Completed |
Pfizer |
2007-12-31 |
| NCT00448331 |
Facilitated Referral for Children Screening Positive for Mental Illness |
https://ClinicalTrials.gov/show/NCT00448331 |
Completed |
Children’s Hospital Medical Center, Cincinnati |
NA |
| NCT00399334 |
PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective Disorders |
https://ClinicalTrials.gov/show/NCT00399334 |
Completed |
Janssen-Cilag, S.A. |
NA |
| NCT00377117 |
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II |
https://ClinicalTrials.gov/show/NCT00377117 |
Completed |
Lawson Health Research Institute |
NA |
| NCT00350493 |
Three Year Follow up of a Randomised Controlled Trial (RCT) of an Intervention for Tobacco Dependence Among Those With a Psychotic Illness |
https://ClinicalTrials.gov/show/NCT00350493 |
Completed |
The University of New South Wales |
2006-02-28 |
| NCT00312598 |
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine |
https://ClinicalTrials.gov/show/NCT00312598 |
Completed |
University of North Carolina, Chapel Hill |
2010-04-30 |
| NCT00291200 |
Enhancing the Prospective Prediction of Psychosis |
https://ClinicalTrials.gov/show/NCT00291200 |
Completed |
Yale University |
2009-02-28 |
| NCT00283517 |
A Registry of Treatment Adherence for Patients With Schizophrenia |
https://ClinicalTrials.gov/show/NCT00283517 |
Completed |
Janssen-Cilag, S.A. |
NA |
| NCT00253240 |
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population |
https://ClinicalTrials.gov/show/NCT00253240 |
Completed |
Lawson Health Research Institute |
NA |
| NCT00222807 |
Schizophrenia, Antipsychotic Treatment and the Risk for Diabetes Mellitus |
https://ClinicalTrials.gov/show/NCT00222807 |
Completed |
University of Pittsburgh |
2016-03-31 |
| NCT00184418 |
The Immune System and Psychiatric Disorders |
https://ClinicalTrials.gov/show/NCT00184418 |
Completed |
Norwegian University of Science and Technology |
2008-01-31 |
| NCT00163865 |
A Pilot Study of Boredom in a Community Sample of Adolescents and a Clinical Sample of Adolescents |
https://ClinicalTrials.gov/show/NCT00163865 |
Completed |
Bayside Health |
2008-06-30 |
| NCT00161057 |
Functional Brain Activation Patterns in Schizophrenia, Measured Before and After Treatment |
https://ClinicalTrials.gov/show/NCT00161057 |
Completed |
UMC Utrecht |
NA |
| NCT00135772 |
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2 |
https://ClinicalTrials.gov/show/NCT00135772 |
Completed |
National Institute on Drug Abuse (NIDA) |
2004-07-31 |
| NCT00070889 |
Brain Cell Injury in Patients With A First Episode of Psychosis |
https://ClinicalTrials.gov/show/NCT00070889 |
Completed |
National Center for Complementary and Integrative Health (NCCIH) |
NA |